NetworkNewsBreaks – EVIO, Inc. (EVIO) Aims to In
Post# of 2022
Life sciences and cannabis testing company EVIO (OTCQB: EVIO) labs provide quality control testing and advisory services to regulated cannabis industry. Testing services are offered nationwide, with eight labs in five states and expansion opportunities in another four states as well as Canada. An article discussing the company reads: “EVIO, Inc. (OTCQB: EVIO), a health sciences company focused on analyzing cannabis, continues to move the bar higher and set the standard when it comes to testing cannabis in each of its laboratory settings in states where the highly regulated plant is now legal. Headquartered in Oregon, EVIO Labs specializes in testing cannabis and industrial hemp flower, extracts and infused products. Its laboratories offer a crucial selection of analytical tests that meet international standards and state-regulated testing guidelines. EVIO Labs recently expanded its testing capabilities with the addition of delta-8 THC to its analyte list for cannabinoid profiling.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer